Your Health, We Care
Vibegron was approved for marketing by the PMDA of Japan on September 21, 2018, and is marketed in Japan by Xinglin Pharmaceutical and Kissei under the trade name beova for the treatment of overactive bladder.
On December 23, 2020, it was approved for marketing by the United States FDA under the trade name gemtesa.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
